When we further analyzed this set of clinical samples, we found that LY6K-positive breast cancer tissues presented a lower E-cadherin, an epithelial marker, expression level, but E-cadherin expression increased in LY6K-negative breast tumor samples (Figure 1B). Here, LY6K is linked to breast carcinoma.